| 注册
首页|期刊导航|基础医学与临床|干扰ELK-3抑制人肝癌细胞的上皮-间质转换

干扰ELK-3抑制人肝癌细胞的上皮-间质转换

李天柱 史铁伟 周静 金光虎 张俊毅 郝丹丹 白春英

基础医学与临床2017,Vol.37Issue(2):211-216,6.
基础医学与临床2017,Vol.37Issue(2):211-216,6.

干扰ELK-3抑制人肝癌细胞的上皮-间质转换

ELK-3 interference inhibits the epithelial-mesenchymal transition of human hepatocellular carcinoma cells

李天柱 1史铁伟 1周静 1金光虎 1张俊毅 1郝丹丹 1白春英1

作者信息

  • 1. 赤峰学院医学院分子医学研究中心,内蒙古赤峰024000
  • 折叠

摘要

Abstract

Objective To investigate the relationship of ELK-3 and epithelial-mesenchymal transition ( EMT) for ex-ploring its possible mechanism .Methods The human hepatocellular carcinoma cells ( HCC) were divided into small interference RNA transfection group and Ras-ELK-3 pathway inhibitor group .The protein level of ELK-3 target gene EGR-1 E-cadherin ,vimentin and p38 in HCC were determined by Western blot analysis .Results The protein level of ELK-3 and its target gene EGR-1 in treated human hepatocellular carcinoma cells significantly decreased as compared with the negative control group (P<0.01).The protein level of E-cadherin was significantly increased (P<0.01), while vimentin and p38 were decreased in HCC cells with ELK-3 interference (P<0.01).Conclusions ELK-3 in-terference can inhibit the epithelial-mesenchymal transition of HCC cells by down-regulating p38.

关键词

ELK-3/肝癌细胞/上皮间质转换/p38

Key words

ELK-3/hepatocellular carcinoma/epithelial-mesenchymal transition/p38

分类

医药卫生

引用本文复制引用

李天柱,史铁伟,周静,金光虎,张俊毅,郝丹丹,白春英..干扰ELK-3抑制人肝癌细胞的上皮-间质转换[J].基础医学与临床,2017,37(2):211-216,6.

基金项目

内蒙古自然科学基金 ()

基础医学与临床

OACSCDCSTPCD

1001-6325

访问量0
|
下载量0
段落导航相关论文